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rupture, and limb loss. It also needs to be cost effective.[2] 
The current screening recommendation for vascular disease 
is restricted to AAA in men older than 65 years with a 
history of smoking.[3-5] The data show that screening for 
asymptomatic carotid disease and PAD does not impact 
on decreasing the incidence of stroke death or of loss of 
limb, but it does correlate with ﬁ  nding a population with 
high cardiac mortality in which intervention would have 
an impact.[6-9]
In our study population, we provided ultrasound of the 
carotid arteries, abdominal aorta, and segmental Doppler 
of the lower extremities. After screening 758 people aged 
40 years or older, we found 61.7% with atherosclerotic 
plaques without stenosis, 12.7% with mild disease, 2.5% 
with intermediate disease, and 1.3% with severe disease. 
The deﬁ  nition of mild, intermediate, and severe disease is 
given in Table 1. This service was modeled after the Dare 
to CARE program in Annapolis, MD.[10]
INTRODUCTION
Data from the National Vital Statistics reports show that 
26% of the total deaths in the USA are due to heart disease 
and 5.7% are due to cerebrovascular disease.[1] Death 
due to heart disease is caused mainly by atherosclerotic 
obstruction of the coronary arteries. Atherosclerosis is 
a systemic disease affecting not only the coronary and 
carotid arteries but also the abdominal aorta and the lower 
extremities. The correlation of death and atherosclerosis 
of the carotid arteries and lower extremity arteries is not 
straightforward as in the coronaries. Therefore, screening 
for carotid disease and peripheral artery disease (PAD) in 
an asymptomatic population is controversial. Screening for 
abdominal aorta aneurysm (AAA) is well established and 
reduces mortality from ruptured aneurysm.
Screening for vascular disease would make sense if we 
could impact on decreasing deaths and morbidity from 
coronary artery disease (CAD), stroke, aortic aneurysm 
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ABSTRACT
Background: Implementation and adaptation of a vascular screening program in a rural community. Methods 
and Results: A vascular screening program was offered free to the general population aged 55 years and older. 
It comprised of ultrasound screening of the carotid arteries, abdominal aorta, and the lower extremity segmental 
Doppler with ankle brachial index measurements. The program was initially developed in Annapolis, MD, and 
adapted to rural Warren, PA. Between March 2008 and June 2009, a total of 758 screenings were completed. 
Mild disease was detected in 12.7% of the population, moderate disease in 2.5% of the population, and severe 
disease in 1.3% of the population; 61.7% of all the participants had atherosclerotic plaques without stenosis and 
45.9% of the participants had a history of smoking, 12.1% diabetes, 81.4% dyslipidemia, 58.3% hypertension, 
and 9.8% heart disease. Conclusion: This model of vascular screening program is an important tool for the 
detection of vascular disease and preventive health counseling. It detects not only vascular disease but its 
associated risk factors. Adequate treatment decreases cardiovascular disease mortality. This program, through 
local sponsorship, is adaptable to the rural community. 
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MATERIALS AND METHODS
We offered free vascular screening for the general population 
aged 55 years and older. Younger people were not rejected 
(which explains the participation of younger individuals). 
We had a group of 1 ultrasound technician, 1 secretary 
coordinator, 1 nurse practitioner, and 3 physicians. The results 
were discussed with each participant and a report was sent to 
their primary care physician . Any severe or critical result was 
referred to our vascular surgeon who would see the patient 
promptly.
The program is offered in a 2-day session: On day 1, there is 
a lecture on vascular disease, including prevention, diagnosis, 
and treatment. Participants receive a voucher for a free 
laboratory test, including lipid proﬁ  le and fasting glucose. 
The lecture is limited to 200 participants. On day 2, there are   
blood pressure measurement with ankle brachial index (ABI) 
calculation, and the ultrasound screening with the results 
annotated by the technician. The ultrasound is done 3 times 
a week until all 200 participants have had their tests done. The 
nurse practitioner discusses all the data with the participant 
and advises on prevention and treatment, including lifestyle 
change, smoking cessation, obesity, use of antiinﬂ  ammatory 
drugs (eg, aspirin), and statins or possible surgical intervention.
The diagnostic criteria and interpretation of carotid stenosis 
follows the Dare to CARE program and is based on the 
Commission for the Accreditation of Vascular Laboratories 
[Table 2].[11]
The screening is now offered every 3 months. It is totally free 
and sponsored by a local foundation and the local community 
hospital. It took the team about 4 months to become 
proﬁ  cient. The hospital offers 2 rooms for the day 2  session. 
The lecture is presented elsewhere at a local auditorium.
All the physicians involved in the lectures (2 internal medicine 
physicians and 1 vascular surgeon) volunteer their time. 
The vascular technician, the nurse practitioner, and the 
secretary coordinator work during their regular shifts. They 
are employed by the hospital. The secretary coordinator also 
organizes the evening lectures.
RESULTS
A total of 758 people were screened. Of these, we have data on 
age, gender, lipid proﬁ  le, fasting blood glucose, blood pressure, 
Table 1: Disease severity
 Carotid 
obstruction 
(%)
Abdominal 
aortic 
aneurysm (cm)
PAD 
(ABI)
Mild 1–39 3–3.9 0.7–0.95
Intermediate 40–59 4–4.9 0.5–0.69
Severe ≥60 ≥5 <0.5
ABI, ankle brachial index; PAD, peripheral artery disease.
Table 2: Carotid duplex velocity interpretation criteria
Category PSV lower Upper EDV lower Upper ICA/CCA lower Upper
Normal 0.1 109.9 0 39.9 0 1.4
Mild: 1%–39% 110 129.9 0 39.9 1.5 2.9
Moderate: 40%–59% 130 169.9 0 39.9 1.5 2.9
Severe: 60%–79% 170 249.9 40 99.9 3 5.9
Critical: 80%–99% 250 999.9 100 999.9 6 99.9
Occluded 0 0 0 0 0 0
PSV, peak systolic velocity; EDV, end diastolic velocity; ICA/CCA, internal carotid artery/common carotid artery velocity ratio, 
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Table 3: Testing results—carotid disease detection
Age group (N) Mild: 1–39% Moderate: 40–59% Severe: ≥ 60%
% n%n%n
40–49 (35) 8.6 3 0.0 0 0.0 0
50–59 (187) 6.4 12 1.6 3 0.5 1
60–69 (225) 8.0 18 2.2 5 0.9 2
70–79 (127) 10.2 13 6.3 8 2.4 3
80–89 (51) 5.9 3 3.9 2 0.0 0
90–99 (2) 0.0 0 0.0 0 0.0 0
All (627) 7.8 49 2.9 18 1.0 6
Including extras (n = 131)
758 7.1 54 2.5 19 1.1 8J Cardiovasc. Dis. Res. Vol. 1 / No 2 94 Available Online: www.jcdronline.org
ultrasound, and ABI of 627 participants. The ultrasound 
results and ABI data were available for all the 758 participants. 
Some data (age, gender, lipid proﬁ  le, fasting blood glucose, and 
blood pressure) were missing from the ﬁ  rst 131 participants 
when we were learning and adapting the program.
All participants live in Warren County, PA. They were in 
the age group of 40–99 years and 62% were women.
There were 45.9% with history of smoking, 12.1% 
with diabetes, 81.4% with dyslipidemia, 58.3% with 
hypertension, and 9.8% with heart disease. 
Mild disease (carotid stenosis ≤ 39%, 0.7 ≤ ABI ≤ 0.95 
or 3.0 cm ≤ AAA ≤ 3.9 cm) was detected in 12.7% of the 
population; moderate disease (carotid stenosis 40–59%, 0.5 
≤ ABI ≤ 0.69 or 4.0 cm ≤ AAA ≤ 4.9 cm) in 2.5% of the 
population and severe disease (carotid stenosis ≥ 60%, ABI 
< 0.5 or AAA ≥ 5.0 cm) in 1.3% of the population; 2.6% 
of the population with vascular disease had no risk factors, 
such as smoking, diabetes, dyslipidemia, and hypertension. 
As expected, the presence of these risk factors increased 
the prevalence of moderate and severe vascular disease 
by 56%, 32%, 444%, and 139%, respectively; 61.7% of 
all the participants had atherosclerotic plaques without 
stenosis. The results of carotid disease, AAA and PAD 
are summarized in Tables 3, 4, and 5. Table 6 shows the 
detection of any vascular disease as a group.
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Table 4: Testing results—AAA
Age group (N) 3 cm ≤ AAA ≤ 3.9 cm 4 cm ≤ AAA ≤ 4.9 cm AAA ≥ 5 cm
%n% n%n
40–49 (35) 0.0 0 0.0 0 0.0 0
50–59 (187) 1.1 2 0.0 0 0.0 0
60–69 (225) 0.4 1 0.0 0 0.0 0
70–79 (127) 1.6 2 1.6 2 0.0 0
80–89 (51) 2.0 1 0.0 0 0.0 0
90–99 (2) 0.0 0 0.0 0 0.0 0
All (627) 1.3 6 0.3 2 0.0 0
Including extras (N = 131)
758 1.1 8 0.3 2 0 0
AAA, abdominal aorta aneurysm.
Table 5: Testing results—PAD
Age group (N) 0.7 ≤ ABI ≤ 0.95 0.5 ≤ ABI ≤ 0.69 ABI < 0.5
%n % n%n
40–49 (35) 2.9 1 0.0 0 0.0 0
50–59 (187) 8.0 15 0.5 1 0.0 0
60–69 (225) 7.6 17 0.0 0 0.0 0
70–79 (127) 10.2 13 2.4 3 0.8 1
80–89 (52) 5.9 3 2.0 1 2.0 1
90–99 (2) 0.0 0 0.0 0 0.0 0
All (627) 7.8 49 0.8 5 0.3 2
Including extras (N = 131)
758 7.3 55 0.9 7 0.3 2
ABI, ankle brachial index, PAD, peripheral artery disease.
Table 6: Vascular disease detection
All age groups (N) Plaque only Mild disease Intermediate disease Severe disease
%n% n %n  % n
627 58.4 366 13.9 87 2.9 18 1.3 8
Including extras (N = 131)
758 61.7 468 12.7 96 2.5 19 1.3 10Available Online: www.jcdronline.org 95 J Cardiovasc. Dis. Res. Vol. 1 / No 2
DISCUSSION
The detection of atherosclerotic plaques in 61.7% of the 
population was found to be signiﬁ  cant. These data alone 
can be used to address lifestyle change and risk factor 
modiﬁ  cation. Plaque, carotid disease, and carotid artery 
intima thickness are known to increase cardiovascular 
mortality.[7,8,12,13] PAD is also strongly correlated with 
CAD[14] As a preventive measure, this program will 
probably have an impact on the incidence of vascular 
diseases and mortality. We hope that advocating the use 
of statins will reverse the progression of atherosclerosis in 
carotid arteries.[15]
 The education provided by this program 
will also decrease the incidence of smoking and obesity. On 
the long run it may also improve diseases, such as diabetes, 
hypertension, and dyslipidemia. A few patients will beneﬁ  t 
immediately from the detection of severe cases in which 
surgery may be indicated to prevent stroke, AAA rupture, 
or limb loss.
Carotid stenosis is responsible for only about 20% of 
ischemic strokes; therefore, more sophisticated tests, 
such as transcranial Doppler for the identiﬁ  cation of 
microemboli may identify high-risk individuals for more 
aggressive intervention.[9,16] 
Our data showed that compared with Annapolis, MD 
(population 36,000), the rural town of Warren, PA 
(population 10,000), had a similar incidence of vascular 
disease. In Annapolis the incidence of  severe carotid 
disease was 1.7% vs. 1.1% in Warren, PAD 6.9% vs. 8.4% 
and AAA 2.2% vs. 1.3%, respectively. Therefore, the impact 
of such interventions does not appear to change from 
urban to rural communities. The Dare to CARE program 
could be implemented in other cities and be sponsored by 
local foundations, hospitals, and health insurance groups. 
Although we did not calculate the cost of such a program, 
it has been shown elsewhere to be $25.00 per participant.[10]
The Dare to CARE vascular screening program is a useful 
tool in preventive medicine. Ultrasound not only detects 
vascular disease but it gives people raw data on which they 
can work to prevent and control diseases, such as diabetes, 
hypertension, dyslipidemia, and atherosclerosis. Although 
screening asymptomatic people for carotid disease and 
PAD is controversial, it does show a high-risk population 
for cardiac death in which intervention is advisable. The 
program is adaptable to the rural setting.
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